Home
Cancer types
Treatments
Support
News
Centres and oncologists
Search
Tuesday, November 10, 2026
Ogkologos.com
Home
Cancer types
Treatments
Support
News
Centres and oncologists
Home
World News
Page 48
World News
World News
ΕΠΙΣΤΗΜΟΝΙΚΑ ΝΕΑ
ΖΩΝΤΑΣ ΜΕ ΚΑΡΚΙΝΟ
ΚΑΡΚΙΝΟΣ
ΚΕΝΤΡΑ ΚΑΡΚΙΝΟΥ – ΟΓΚΟΛΟΓΟΙ
Myths and Facts
ΝΕΑ - ΤΥΠΟΙ ΚΑΡΚΙΝΟΥ
ΤΥΠΟΙ ΚΑΡΚΙΝΟΥ
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Large DFS Benefit from Adjuvant Cemiplimab Among Patients at High Risk...
Ogkologos
-
June 18, 2025
0
French Senate Committee Backs ESMO Call to Revise EU Regulation to...
Ogkologos
-
June 17, 2025
0
Structured Exercise Programme Initiated Soon After the Completion of Adjuvant Chemotherapy...
Ogkologos
-
June 17, 2025
0
Tarlatamab Prolongs OS Over Chemotherapy Among Patients with SCLC Whose Disease...
Ogkologos
-
June 16, 2025
0
ESMO Announces Results of 2025 Elections
Ogkologos
-
June 14, 2025
0
FDA Grants Accelerated Approval to Telisotuzumab Vedotin-tllv for NSCLC with High...
Ogkologos
-
June 13, 2025
0
EMA Recommends Extension of Therapeutic Indications for Brentuximab Vedotin
Ogkologos
-
June 12, 2025
0
ESMO Calls for Oncology-Specific Safeguards in the EU Critical Medicines Act
Ogkologos
-
June 11, 2025
0
Elinzanetant Leads To a Significantly Lower Frequency of Vasomotor Symptoms Associated...
Ogkologos
-
June 11, 2025
0
ESMO Calls for Cancer to Be at the Core of the...
Ogkologos
-
June 10, 2025
0
1
...
47
48
49
...
432
Page 48 of 432
MOST POPULAR
Rare Disease Day 2026: Advancing equity for people living with rare...
February 27, 2026
Sacituzumab Govitecan Demonstrates Overall Survival Benefit Over Chemotherapy in Patients with...
September 18, 2023
FDA Grants Regular Approval to Rucaparib for Metastatic Castration-Resistant Prostate Cancer
January 29, 2026
Precision drug slows progression of advanced breast cancer
September 21, 2021
Load more
HOT NEWS
New on NCI’s Websites for November 2024
Talazoparib Does Not Prolong OS in BRCA1/2-mutated, HER2-negative Advanced Breast Cancer
EMA Recommends Granting a Marketing Authorisation for Datopotamab Deruxtecan
Access to Cancer Medicines and Clinical Trials Show Stark Variations Across...
Ελληνικά
English (UK)